Table 2 Baseline and changes of cytokine levels from baseline to week 12 of pitavastatin treatment vs. placebo

2.01 (1.71 –2.42)

1.28 (0.39–2.87)

0.99 (0.30 –1.88)

0.820

153.80 (132.90–180.80)

37.10 (− 13.40–81.50)

33.10 (8.44 –105.00)

0.865

9.51 (6.32–11.16)

2.16 (0.49–5.54)

1.74 (0.65–3.54)

0.872

3.89 (3.46–4.70)

1.82 (1.21–2.37)

1.35 (1.08 –2.20)

0.261

7.66 (6.55 –9.50)

6.73 (1.00–33.3)

9.29 (0.09 –26.40)

0.966

20.59 (11.55–34.30)

− 0.32 (− 15.10–4.72)

1.38 (− 12.70–11.70)

0.560

23.87 (20.81–29.57)

57.00 (18.50–89.70)

53.6 (5.03–171.00)

0.551

66.40 (53.63–76.46)

42.1 (21.10–53.90)

34.20 (14.80–66.00)

0.922

14.38 (3.38–17.04)

2.19 (0.00–10.30)

2.36 (0.00 –10.50)

0.958

19.24 (13.43–29.46)

9.39 (1.16–14.80)

8.94 (4.81–15.90)

0.601

1.60 (1.16 –2.18)

1.23 (0.01–2.26)

1.06 (0.00–1.79)

0.768

14.23 (11.49–19.67)

0.00 (− 4.03–1.57)

1.19 (− 2.34–3.14)

0.086

211.20 (167.1 – 244.5)

173.00 (85.10–219.00)

129.00 (68.8–199.00)

0.747

90.88 (70.86 – 110.20)

5.97 (− 6.60–17.70)

8.76 (− 9.80 –17.90)

0.790

85.25 (75.04–98.90)

27.10 (18.30–36.60)

20.50 (11.60–29.00)

0.023

70.84 (59.80–76.97)

0.79 (− 11.40–10.80)

4.90 (− 3.33 –8.48)

0.622

57.01 (48.31–66.63)

8.67 (0.24–14.40)

3.52 (0.00–13.00)

0.223

14.40 (14.40–74.01)

0.00 (− 2.70–12.00)

0.00 (0.00–34.30)

0.269

613.40 (466.00–921.90)

133.00 (17.30–201.00)

103.00 (20.70–158.00)

0.870

121.70 (100.80–160.50)

− 18.00 (− 49.10 – 0.62)

− 29.8 (− 43.80–−7.81)

0.520

3.64 (1.00 –4.42)

6.64 (3.80–14.80)

6.21 (3.56–20.90)

0.716

443.90 (368.50–482.90)

610.00 (188.00 –1618.00)

762.00 (87.80–1702.00)

0.368

409.70 (319.40–521.90)

359.00 (240.00–443.00)

305.00 (143.00–423.00)

0.601

7240.00 (5799.00–9174.00)

− 2626.00 (− 5815.00–−506.00)

−1226.00 (− 3419–236.00)

0.107

52.70 (43.67–60.75)

25.10 (6.94–56.60)

21.90 (7.85-37.20)

0.475

103.20 (81.34–164.90)

22.10 (− 12.10–47.90)

23.20 (0.07 –54.70)

0.331

1.19 (1.00 –1.86)

0.12 (− 0.21–0.67)

0.17 (− 0.27 –0.78)

0.596